Work

Workshop on integration site analysis during long term follow-up for gene therapies with integrating viral vectors (Catapult’s regulatory round-up – September 2024)

Year: 2024

Type: other

Abstract: On 14th November 2024, the FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors. In this workshop a panel of external experts will discuss the risk of insertional mutagenesis and best practices for ISA method design, data analysis, and clinical inter...

Source: Industrias Culturais (Universidade de Coimbra)

DOI: 10.58079/12prz

Author: Adelage

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6899100134

Cites:

Cited by:

Related to: